Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 13Colorectal Neoplasms 9Neoplasm Metastasis 8Peritoneal Neoplasms 6Pancreatic Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 6Appendiceal Neoplasms 6Stomach Neoplasms 5Carcinoma, Hepatocellular 5Anus Neoplasms 5Sarcoma 4Rectal Neoplasms 4Colonic Neoplasms 4Liver Neoplasms 3Carcinoma, Transitional Cell 3Pseudomyxoma Peritonei 2Mesothelioma, Malignant 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Anal Canal Carcinoma 2Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Urethral Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pleural Neoplasms 1Pancoast Syndrome 1

Interventions

Gemcitabine 6Specimen Handling 4Cisplatin 4pembrolizumab 3enfortumab vedotin 3atezolizumab 3Nivolumab 3Magnetic Resonance Spectroscopy 3Carboplatin 3vinflunine 2eribulin 2avelumab 2Standard of Care 2Biopsy 2vandetanib 1tocilizumab 1tamibarotene 1rucaparib 1relatlimab 1pegfilgrastim 1merphos 1guadecitabine 1genexol-PM 1dehydroftorafur 1carotuximab 1Vitamin D 1Vinblastine 1Ramucirumab 1Radiotherapy 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Ureteral Neoplasms × Mitomycin × Clear all
NCT03617913 2023-01-06

Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer

Mayo Clinic

Phase 2 Completed
2 enrolled 8 charts
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡